|
MechanismLysostaphin stimulants |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with NXXI SUB LLC
0 Patents (Medical) associated with NXXI SUB LLC
100 Deals associated with NXXI SUB LLC
100 Translational Medicine associated with NXXI SUB LLC